Peptide-peptidase inhibitor conjugates and methods of using...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01)

Patent

CA 2646598

Peptide-peptidase inhibitor conjugate molecules are disclosed. These conjugate molecules are useful as agents for the treatment and prevention of metabolic and cardiovascular diseases, disorders, and conditions. Such diseases, conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, and other diabetes-related disorders.

La présente invention concerne des molécules de conjugué inhibiteur de peptidase-peptide. Ces molécules de conjugué conviennent comme agents pour le traitement et la prévention de maladies, de troubles et de pathologie métaboliques et cardio-vasculaires. Ces maladies, ces pathologies et ces troubles comprennent notamment l'hypertension, la dyslipidémie, la maladie cardio-vasculaire, les troubles de l'alimentation, la résistance à l'insuline, l'obésité et le diabète de tout type et d'autres troubles liés au diabète.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Peptide-peptidase inhibitor conjugates and methods of using... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide-peptidase inhibitor conjugates and methods of using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide-peptidase inhibitor conjugates and methods of using... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1606697

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.